Amanote Research
Register
Sign In
Erratum: The Efficacy and Safety of Anti‐PD‐1/Pd‐l1 Antibodies Combined With Chemotherapy or CTLA4 Antibody as a First‐line Treatment for Advanced Lung Cancer
International Journal of Cancer
- United States
doi 10.1002/ijc.31820
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
December 7, 2018
Authors
Bo Zhang
Qiong Wu
Publisher
Wiley